Results 121 to 130 of about 35,531 (245)
Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis [PDF]
Giovanni Palladini +10 more
openalex +1 more source
Multiple Myeloma : an update on disease biology and therapy [PDF]
Multiple myeloma is a malignancy of immunoglobulin producing plasma cells. Clinical features include bone pain due to lytic bone lesions or pathological fractures, anemia, symptomatic hypercalcemia, renal insufficiency, recurrent infections and ...
Cook, Rachel J., Dingli, David
core
ABSTRACT Aims Elevated serum free light chain (FLC) and B‐cell activating factor (BAFF) levels have been reported to be associated with B‐cell activation and to serve as biomarkers reflecting disease severity in various diseases. However, limited investigation has been conducted in the context of chronic liver disease (CLD), and the aim of this study ...
Motoh Iwasa +8 more
wiley +1 more source
Abstract Background Hereditary transthyretin (ATTRv) amyloidosis was first described in Sweden in the late 1960s. Selected patient data have been collected since then and have now been transferred to a national quality registry. Methods This is the first report from SveATTR—a longitudinal Swedish web‐based registry open for TTR variant carriers and ...
Lotta Stenberg +7 more
wiley +1 more source
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis
Background/Objectives: Antibody light chains form amyloid fibrils that lead to progressive tissue damage in amyloid light chain (AL) amyloidosis. The properties of each patient’s unique light chain appear to determine its propensity to form amyloid.
Gareth J. Morgan +4 more
doaj +1 more source
Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type [PDF]
Background. Renal amyloidosis results from protein misfolding and leads to progressive renal insufficiency. Few data are available concerning the relevance of the histomorphological patterns and the dynamics of the disease process. Methods.
Hopfer, Helmut +2 more
core
Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis [PDF]
Μαρία Παπαθανασίου +12 more
openalex +1 more source
SGLT‐2 inhibitors for cardiac amyloidosis: Hype or hope?
European Journal of Clinical Investigation, Volume 55, Issue 11, November 2025.
Flavio Tangianu +3 more
wiley +1 more source

